Kus, F.; Guven, D.C.; Yildirim, H.C.; Chalabiyev, E.; Koc, I.; Tatar, O.D.; Sirvan, F.; Sahin, Y.B.; Karaca, E.; Kabukcu, F.;
et al. Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score. J. Clin. Med. 2025, 14, 1954.
https://doi.org/10.3390/jcm14061954
AMA Style
Kus F, Guven DC, Yildirim HC, Chalabiyev E, Koc I, Tatar OD, Sirvan F, Sahin YB, Karaca E, Kabukcu F,
et al. Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score. Journal of Clinical Medicine. 2025; 14(6):1954.
https://doi.org/10.3390/jcm14061954
Chicago/Turabian Style
Kus, Fatih, Deniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, Ilgin Koc, Omer Denizhan Tatar, Firat Sirvan, Yigit Berk Sahin, Ece Karaca, Furkan Kabukcu,
and et al. 2025. "Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score" Journal of Clinical Medicine 14, no. 6: 1954.
https://doi.org/10.3390/jcm14061954
APA Style
Kus, F., Guven, D. C., Yildirim, H. C., Chalabiyev, E., Koc, I., Tatar, O. D., Sirvan, F., Sahin, Y. B., Karaca, E., Kabukcu, F., Bay, B. A., Kavruk, O., & Erman, M.
(2025). Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score. Journal of Clinical Medicine, 14(6), 1954.
https://doi.org/10.3390/jcm14061954
